CNCB CAPITAL
CNCB CAPITAL
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-05 | Intellective Bio | CNCB Capital investment in Series C - Intellective Bio | 500 M CNY |
| 2022-07-26 | HaploX Biotechnology | CNCB Capital investment in Series D - HaploX Biotechnology | N/A |
| 2022-06-30 | Green Bamboo Bio | CNCB Capital investment in Series C - Green Bamboo Bio | N/A |
| 2021-09-16 | IASO Biotherapeutics | CNCB Capital investment in Series C - IASO Biotherapeutics | 108 M USD |
| 2020-10-14 | Broncus Technologies | CNCB Capital investment in Series C - Broncus Technologies | N/A |
More informations about "CNCB Capital"
CNCB Capital - Investments, Portfolio & Company Exits
Dec 21, 2022 CNCB Capital has made 6 investments. Their most recent investment was on Dec 21, 2022, whenECARX raised obfuscated .See details»
CNCB Capital Company Profile: Service Breakdown
CNCB Investment is an investment banking firm, founded in 1984 and headquartered in Hong Kong. The firm provides services in areas such as financial advisory, investment and financing, capital operation, mergers and โฆSee details»
Ni Zhengdong - CB Insights
Jun 28, 2022 CNCB Capital is a wholly-owned subsidiary of CNCB Investment, which is itself a subsidiary of China CITIC Bank. As of December 31, 2021, CNCB Capital managed more than โฆSee details»
CNCB Capital - Updates, News, Events, Signals & Triggers
Recent News & Activity Edit Recent News & Activity Section Funding RoundโขDec 21, 2022 ECARX raised $65,000,000 / Post Ipo Debt from CNCB Capital and SPDB International โฆSee details»
S&P Global Ratings
Oct 18, 2021 CNCB Investment receives sufficient funding and capital support from the parent bank, including multiple capital injections and significant amount of direct credit facilities.See details»
Zero2IPO Group Portfolio Investments, Zero2IPO Group Funds, โฆ
Jun 28, 2022 CNCB Capital is a wholly-owned subsidiary of CNCB Investment, which is itself a subsidiary of China CITIC Bank. As of December 31, 2021, CNCB Capital managed more than โฆSee details»
CNCB Capital taps FISโ cloud-based solution - The Asset
Aug 15, 2023 CNCB Capital is wholly owned by CNCB (Hong Kong) Investment, which is an offshore subsidiary of China CITIC Bank Corporation. The Hong Kong-based HKSFC-licensed corporation was seeking a technology partner โฆSee details»
CNCB Capital - Unicorn Nest
โ The round was led by CDH Baifu, and followed by CCB International, with strong participation from Everbright Limited, Co-Stone Capital, CNCB Capital and Plaisance Capital. โ Current โฆSee details»
BBVA concludes the sale of nearly its entire stake in CNCB
BBVA concludes the sale of nearly its entire stake in CNCBSee details»
- CNCB (Hong Kong) Investment Limited
An open-ended fund company (โOFCโ) is an open-ended collective investment scheme established under the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) โฆSee details»
ไฟก้ (้ฆๆธฏ)่ณๆฌๆ้ๅ ฌๅธ · CNCB (Hong Kong) Capital Limited · โฆ
ไฟก้ (้ฆๆธฏ)่ณๆฌๆ้ๅ ฌๅธ (LEI# 254900IQ49HKI6O0OH06) is a legal entity registered with . The address is 2001-2005, 20/F., AIA Central, 1 Connaught Road Central, Hong Kong, 999077, HK.See details»
Our Heritage - China CITIC Bank International
About CNCBI Our Heritage Our Management Awards & Recognition Community & Us Investor Relations Media CentreSee details»
Fitch Affirms CNCB (Hong Kong) Investment at 'BBB+'; Outlook โฆ
Sep 6, 2024 Positive rating action will only be possible if CNCB is upgraded, as CNCB Investment's rating is equalised with that of the parent. For the rating sensitivities of CNCB, โฆSee details»
About China CITIC Bank International
Harnessing the strengths of our parent bank China CITIC Bank (CNCB), we are CNCB's overseas platform for pursuing business expansion in Hong Kong, Asia and internationally.See details»
โTurbo button has been hitโ: Cowpland-backed NuvoBio among โฆ
11 hours ago Access to cutting-edge lab space Thankfully for Biggar, a new organization is here to give him a leg up. Launched last fall by former executives of Ottawa-born biotech trailblazer โฆSee details»
ECARX - Funding, Financials, Valuation & Investors
In funding over 7 rounds. Their latest funding was raised on Dec 21, 2022 from a Post-IPO Debt round. ECARX is registered under the ticker NASDAQ:ECX . ECARX is funded by 12 โฆSee details»
BBVA increases capital by 2.4 billion euros
Dec 23, 2015 BBVAโs decision to sell a 5.1% stake in CNCB will allow the Group to anticipate the new capital requirements under Basel III. The transaction will boost BBVAโs Basel III fully โฆSee details»
Stock Markets, Business News, Financials, Earnings - CNBC
Get the latest stock market news, business updates, financials, and earnings reports from CNBC.See details»
Browse - GSA - CNCB-NGDC - National Genomics Data Center
Submitter: Yumeng Chen ([email protected]) Organization: Zhejiang University Date submitted: 2024-10-04See details»